Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

The catheters shown here are for (from top to bottom) Boston Scientific’s Farapulse, Medtronic’s Affera, Medtronic’s Pulse Select, J&J’s Varipulse, and Abbott’s Volt. [Image courtesy of ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/27/24, Medtronic PLC (Symbol: MDT), DENTSPLY SIRONA Inc (Symbol: XRAY), and Danaher Corp (Symbol: DHR) will all trade ex ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

Boston Scientific has updated its instructions for doctors using catheter technology to treat ... startups and large companies such as Medtronic for the business section. He reports on new ...

balloon catheters, guide wires, and transcatheter aortic valve replacement (TAVR) systems. With a strong commitment to improving patient outcomes, Medtronic continually invests in research and ...

Dec 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's (BSX.N), opens new tab catheters used in a type of minimally invasive surgery as ...

Catheters Market Insights The global catheters market was valued at US$ 43.18 Bn in 2022 and is forecast to reach a value of US$ 84.50 Bn by 2030 at a CAGR of 6.4% between 2023 and 2030 BURLINGAME, CA ...